ID
24028
Description
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone; ODM derived from: https://clinicaltrials.gov/show/NCT00528879
Link
https://clinicaltrials.gov/show/NCT00528879
Keywords
Versions (2)
- 7/23/17 7/23/17 -
- 7/23/17 7/23/17 -
Uploaded on
July 23, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Type 2 Diabetes NCT00528879
Eligibility Type 2 Diabetes NCT00528879
- StudyEvent: Eligibility
Description
key exclusion criteria
Description
ID.7
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0004002
- UMLS CUI [1,2]
- C0001899
Description
ID.8
Data type
boolean
Alias
- UMLS CUI [1]
- C1278039
Description
ID.9
Data type
boolean
Alias
- UMLS CUI [1]
- C1657311
Description
ID.10
Data type
boolean
Alias
- UMLS CUI [1]
- C0810250
Description
ID.11
Data type
boolean
Alias
- UMLS CUI [1]
- C0600061
Description
ID.12
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0443343
- UMLS CUI [1,2]
- C0012634
Similar models
Eligibility Type 2 Diabetes NCT00528879
- StudyEvent: Eligibility
C0011860 (UMLS CUI [1,2])
C0001899 (UMLS CUI [1,2])
C0012634 (UMLS CUI [1,2])